Founded in 1933 by philanthropist Samuel S. Fels, the Fels Cancer Institute for Personalized Medicine has a long-standing legacy of pioneering cancer research. Our scientists investigate the molecular, biochemical, and genetic foundations of cancer, working to translate fundamental discoveries into targeted therapies. With a focus on purposeful medicine, our research spans from the bed to the bench, and back to the bedside, ensuring that discoveries don’t remain in labs—they reach the patients who need them most. 

The Fels Cancer Institute for Personalized Medicine is home to a distinguished team of researchers, physician-scientists, and educators dedicated to advancing cancer treatment. Our faculty includes world-renowned leaders in molecular oncology, cancer genomics, and translational research. Their work has led to game-changing discoveries in drug resistance, immunotherapy, and targeted cancer treatments. Our collaborative environment fosters innovation, bringing together expertise from multiple disciplines to drive the next generation of cancer breakthroughs.